Medication info
Sitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Sitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.37mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202102017 · Approved 2021.03.04 · Insurance code 645605600

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medicine is used to help control blood glucose in patients with type 2 diabetes alongside diet and exercise therapy. Initially, it can be administered alone, and if sufficient blood glucose control is not possible with monotherapy, it is used in combination with metformin. Additionally, if blood glucose control is difficult with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be used in combination. It also improves blood glucose control when combination therapy with various medications is ineffective. Thus, it helps in efficiently controlling glucose levels in diverse situations.

Dosage and Administration

Adult dosage

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration; therefore, if symptoms such as skin rash or difficulty in breathing occur, it should be discontinued immediately, and a doctor should be consulted. There is a risk of developing serious pancreatic diseases such as pancreatitis while taking this medication; hence, if symptoms like abdominal pain, vomiting, or loss of appetite appear, immediate notification to healthcare personnel is necessary. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and those who are allergic to this drug or its components should avoid it. Patients with impaired renal function need dosage adjustments; thus, renal function tests should be performed, and usage should follow a doctor's guidance. Hypoglycemia may occur when taking this drug alone or in combination with other antidiabetic medications; therefore, it is essential to be aware of hypoglycemic symptoms and check blood sugar levels frequently if necessary. During treatment with this medication, side effects such as headache, upper respiratory infections, rhinitis, diarrhea, nausea, indigestion, dizziness, increased blood triglycerides, elevated low-density lipoprotein, hyperglycemia, weight loss, hypertension, hypernatremia, and erectile dysfunction may occur, so if symptoms are severe or persistent, consultation with medical professionals is advised. If symptoms like severe joint pain or blisters on the skin appear, the use of this medication should be stopped immediately and specialist care should be sought. Pregnant or breastfeeding women are advised to avoid this medication, and its safety has not been established in children or adolescents under 18 years of age. Elderly patients are at risk of reduced renal function, so regular kidney function tests before and after taking this medication are necessary. In case of overdose, it is essential to visit a hospital immediately for appropriate treatment, and this drug can be partially removed by hemodialysis. There may be interactions with other medications, so inform healthcare professionals of any other medications being taken.

Side effects

  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 30 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicle-like pemphigus
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure and should be kept at room temperature between 1 and 30 degrees Celsius for safety. This ensures that the effectiveness of the medication is maintained and prevents degradation.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.